Catalyst Wire Dossier Catalyst Wire Dossier

sunitinib/axitinib

sunitinib and axitinib · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for sunitinib/axitinib, covering 2022-02-18 to 2022-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

See pricing